Content Hub

Check out exclusive interviews with our expert speakers below to learn more about what you can expect to hear live at the 3rd Targeted Radiopharmaceuticals Summit US 2024

William van der Touw

Exclusive Speaker Interview with Actinium Pharmaceuticals, William van der Touw

In this exclusive interview, William was able to share with us Actinium’s strategic rationale, combination approach, and thoughts on novel targets. With their recent clinical trials making waves these exclusive insights reaffirm why the field is charged with excited anticipation to what’s on the horizon as we unite with the common goal to “treat more patients and bolster innovation in the field”.